NCT04458636View on ClinicalTrials.gov

Stratified TreAtment to Reduce Risk in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

February 28, 2020

Study Completion Date

April 30, 2020

Conditions
COPD Exacerbation
Interventions
DRUG

Prednisolone

Oral

Trial Locations (1)

Unknown

Nuffield Department of Medicine, Oxford

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

University of Oxford

OTHER

NCT04458636 - Stratified TreAtment to Reduce Risk in COPD | Biotech Hunter | Biotech Hunter